筛选
科学数据
统计数据
共检索到25条 ,权限内显示50条;
Data from: A reliability study of colour-Doppler sonography for the diagnosis of chronic cerebrospinal venous insufficiency shows low inter-rater
- 负责人：
- DOI：
- doi:10.5061/dryad.7k048
- 摘要：
- Objective: Chronic cerebrospinal venous insufficiency (CCSVI) has been extremely variable associated with multiple sclerosis in color-Doppler
Data from: A survey of risk tolerance to multiple sclerosis therapies
- 负责人：
- DOI：
- doi:10.5061/dryad.tg142pt
- 摘要：
- ican Research Committee on Multiple Sclerosis (NARCOMS) Registry’s online cohort and the National Multiple Sclerosis Society were invited to complete
Data from: Head-to-head drug comparisons in multiple sclerosis: urgent action needed
- 负责人：
- DOI：
- doi:10.5061/dryad.h5g7nt7
- 摘要：
- Disease-modifying drugs are changing the natural history of multiple sclerosis (MS). However, currently available clinical trial data ar
Data from: Is the association between health-related quality of life and fatigue mediated by depression in patients with multiple sclerosis
- 负责人：
- DOI：
- doi:10.5061/dryad.vp955
- 摘要：
- with multiple sclerosis (MS). Design: A cross-sectional study. Setting: Tertiary urban hospital. Participants: One hundred and eight patients (54% women) with MS particip
Data from: Effect of dalfampridine on information processing speed impairment in multiple sclerosis
- 负责人：
- DOI：
- doi:10.5061/dryad.sd32fh5
- 摘要：
- ) in multiple sclerosis (MS). Methods: In this randomized, double-blind, placebo-controlled trial, we included patients with a score on the Symbol Digit Modalities Test (SDMT
Data from: Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis
- 负责人：
- DOI：
- doi:10.5061/dryad.3jd86nj
- 摘要：
- in relapsing-remitting multiple sclerosis (RRMS), and relapse rate in the pooled Phase III studies in relapsing multiple sclerosis (RMS). Methods: Brain MRI
Data from: “Gaming the System”: a qualitative study on the price of drugs for multiple sclerosis
- 负责人：
- 关键词：
- DOI：
- doi:10.5061/dryad.vn5js14
- 摘要：
- t manufacture multiple sclerosis disease-modifying therapies. Methods: Four leaders in biotech who have been directly involved in multiple sclerosis disease
syndrome with conversion to multiple sclerosis
- 负责人：
- 关键词：
- multiple sclrosis;clinically isolated syndrome;immunoglobulin free light chains;oligoclonal bands
- DOI：
- doi:10.5061/dryad.464vm
- 摘要：
- on to multiple sclerosis (MS) after 2 years (CIS-MS), patients who remained stable both clinically and radiologically after 2 years (CIS-nonMS), patients with non-inflammatory
Data from: Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis
- 负责人：
- 关键词：
- 14 All Clinical Neurology 41 Multiple sclerosis 54 Cohort studies; 58 Natural history studies (prognosis);Neurofilament light chain
- DOI：
- doi:10.5061/dryad.msbcc2ftm
- 摘要：
- ores of 3.0, 4.0 and 6.0 and conversion to secondary progressive (SP) MS. Results: The median (interquartile range) pNfL was 7.5 (4.1) pg/ml in controls and 11.4 (9.6) pg/ml in MS
Data from: Cumulative Gadodiamide administration leads to brain Gadolinium deposition in early MS
- 负责人：
- DOI：
- doi:10.5061/dryad.04df893
- 摘要：
- Objective: Frequent administration of gadolinium-based contrast agents in multiple sclerosis (MS) may increase signal intensity (SI) unenhanced T1-WI
